Showing posts with label Michael Moore. Show all posts
Showing posts with label Michael Moore. Show all posts

12.29.2007

Name Your Best Films/Documentaries/Books of 2007?

(And yes, if you have WORSTies, you can cite those, too.)

While Time Magazine and CNN and all the usual suspects rush to TELL US what films, books, and yes, even scandals were the best and worst of 2007, we're all thinking people here who don't need to be told what we can reason for ourselves.

With this in mind, what films/documentaries and books did YOU find to be the best of 2007?

Some of my big favorite books (and they would go on a big favorites list that spans more than just this year, btw) also happened to find their way onto my Christmas wish list, and I've already devoured two. These are:

* "Touch and Go" - Studs Terkel's excellent memoirs (he's a national treasure!)
* "The Omnivore's Dilemma" - Michael Pollan, an excellent follow-up to his mind-opening botany book that discusses how Americans really ARE what we eat
* "Deep Economy" - a must-read by Bill McKibben, a Vermont neighbor, that gives us a real eye-opener of an understanding of how the economy, much of which escapes our attention, drives our lives and politics and the future of this planet

But I can't fail to note the late, forever great Kurt Vonnegut's last book that I literally inhaled, "A Man Without A Country".

As for films and documentaries, I would rank "An Unreasonable Man" (about Ralph Nader), Michael Moore's "Sicko", and "The Ghosts of Abu Ghraib" among a slew of excellent works that I saw this year.

What about your favorites?

6.13.2007

"Diagnosis: Conflict of Interest"

Perhaps another reason to see Michael Moore's "Sicko"? Or just another indication of how much the FDA is in the pocket of pharmaceutical companies who decide what your doctor knows about treating you with what drug?

THE revelation that the diabetes drug Avandia can potentially cause heart disease is the latest in a string of pharmaceutical disappointments. Vioxx was pulled from the market in 2004 because it doubled the risks for heart attacks and strokes. Eli Lilly recently paid $750 million to settle lawsuits alleging that Zyprexa causes diabetes. Many have criticized the Food and Drug Administration as being too lax about monitoring drug safety.

While those criticisms have merit, there is another culprit: the transformation of continuing medical education into an enterprise for drug marketing. The chore of teaching doctors how to practice medicine has been handed to the pharmaceutical industry. As a result, dangerous side effects are rarely on the curriculum.

Most states require that doctors obtain a minimum number of credit hours of continuing medical education each year to maintain their medical licenses. Not so long ago, most of these courses were produced and paid for by universities and medical associations. But this has changed drastically over the past decade.

According to the most recent data available from the national organization in charge of accrediting the courses, drug-industry financing of continuing medical education has nearly quadrupled since 1998, from $302 million to $1.12 billion. Half of all continuing medical education courses in the United States are now paid for by drug companies, up from a third a decade ago. Because pharmaceutical companies now set much of the agenda for what doctors learn about drugs, crucial information about potential drug dangers is played down, to the detriment of patient care.